Time course of platelet a granule release in acute myocardial infarction treated with streptokinase

Heart

Volumn 75, Issue 2, 1996, Pages 141-144

  Frandsen, Niels Joørgen ^a,b   Winther, Kaj ^a   Pedersen, Flemming ^a   Christiansen, Ib ^a   McNair, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE   (Denmark)

Author keywords

Aspirin; Myocardial infarction; Platelet a granule; Streptokinase

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; STREPTOKINASE; THROMBOCYTE FACTOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; THROMBOCYTE ALPHA GRANULE; TIME;

EID: 0030043968     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.2.141     Document Type: Article

References (13)

1. Sylvén C, Karlberg K-E, Chen J, Hagerman I, Egberg N, Bergström K. Enhanced platelet function in acute myocardial infarction is attenuated by streptokinase treatment. J Intern Med 1992;231:595-600.
2. Udvardy M, Harsfalvi J, Boda Z, Rak K. Beta thromboglobulin and increased platelet activation after streptokinase treatment of acute myocardial infarction. Am J Cardiol 1992;70:837-8.
3. Ffrench P, McGregor LJ, Berruyer M, et al. Comparative evaluation of plasma thrombospondin, beta-thromboglobulin and platelet factor 4 in acute myocardial infarction. Thromb Res 1985;39:619-24.
4. Galino A, Häberli A, Hess T, Mombelli G, Straub PW. Fibrin formation and platelet aggregation in patients with acute myocardial infarction: effects of intravenous and subcutaneous low-dose heparin. Am Heart J 1986;112:285-90.
5. Seitz R, Leising H, Liebermann A, Rohner I, Gerdes H, Egbring R. Possible interaction of platelets and adrenaline in the early phase of acute myocardial infarction. Res Exp Med 1987;187:385-93.
6. Jaffe AS, Lee RG, Perez JE, Geltman EM, Wilner GD, Sobel BE. Lack of elevation of platelet factor IV in plasma from patients with myocardial infarction. J Am Coll Cardiol 1984;4:653-9.
7. Jang I-K, Vanhaecke J, De Geest H, Verstrate M, Collen D, Van Der Werf F. Coronary thrombolysis with recombinant tissue-type plasminogen activator: patency rate and regional wall motion after 3 months. J Am Coll Cardiol 1986;8:1455-60.
8. Ganz W, Geft I, Shah PK. Intravenous streptokinase in evolving acute myocardial infarction. Am J Cardiol 1984; 53:1209.
9. Harrison DG, Ferguson DW, Collins SM, et al. Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions. Circulation 1984; 69:991-9.
10. Kaplan KL, Owen J. Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981;57:199-202.
11. Kaplan KL, Owen J. Plasma levels of platelet secretory proteins. Crit Rev Oncol Hematol 1984;5:235-55.
12. Bertolino G, Noris P, Previtali M, et al. Platelet function after in vivo and in vitro treatment with thrombolytic agents. Am J Cardiol 1992;69:457-61.
13. Carrieri P, Orefice G, Indaco A. No effect of acetylsalicylic acid on β-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. Stroke 1986;17:1153-5.